Related references
Note: Only part of the references are listed.Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
Tatsuo Kanda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma
Maiko Yoshida et al.
ONCOLOGY LETTERS (2019)
Validation of a novel model for the early detection of hepatocellular carcinoma
Philip M. Hemken et al.
CLINICAL PROTEOMICS (2019)
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
Tomi Jun et al.
HEPATOLOGY COMMUNICATIONS (2019)
Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA
Jiali Wu et al.
CANCER BIOMARKERS (2018)
PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study
Sarka Svobodova et al.
IN VIVO (2018)
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
Sang Joon Park et al.
MEDICINE (2017)
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
Xiumei Wang et al.
INFECTIOUS AGENTS AND CANCER (2017)
Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation
Jianjun Gao et al.
DRUG DISCOVERIES AND THERAPEUTICS (2017)
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data
Rentao Yu et al.
BMC CANCER (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation
Seok-Hwan Kim et al.
HEPATOBILIARY SURGERY AND NUTRITION (2016)
Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma
Jufeng Xia et al.
DRUG DISCOVERIES AND THERAPEUTICS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Nicolas Pote et al.
JOURNAL OF HEPATOLOGY (2015)
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma
Seung In Seo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
Yu-Sheng Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma
Fumitoshi Hirokawa et al.
HEPATOLOGY RESEARCH (2014)
A Combination of α-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma
Judith M. Ertle et al.
DIGESTION (2013)
Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver
Wladimir Faber et al.
SURGERY (2013)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline
Namiki Izumi
ONCOLOGY (2010)
Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve
Nancy R. Cook
CLINICAL CHEMISTRY (2008)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus
BJ McMahon et al.
ANNALS OF INTERNAL MEDICINE (2001)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
